Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2003-07-01
2010-12-14
Canella, Karen A (Department: 1643)
Chemistry: molecular biology and microbiology
Vector, per se
C424S093200, C424S093600
Reexamination Certificate
active
07851213
ABSTRACT:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer.
REFERENCES:
patent: 5833975 (1998-11-01), Paoletti et al.
patent: 6780586 (2004-08-01), Gish et al.
patent: 7217421 (2007-05-01), McArthur et al.
patent: WO 02/00677 (2002-01-01), None
patent: WO 03/084467 (2003-10-01), None
Tartaglia et al, Vaccine, 2001, vol. 19, pp. 2571-2575.
Verma et al (Nature, 1997, vol. 389, pp. 239-242).
Eck et al (Gene-Based Therapy, In: The Pharmacological Basis of Therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-101).
Orkinl (“Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, 1995).
Abstract of Algarra et al International Journal of Clinical and Laboratory Research, 1997, vol. 27, pp. 95-102).
Bodey et al (Anticancer Research, Jul.-Aug. 2000, vol. 20, pp. 2665-2676).
Lauritzsen et al (International Journal of Cancer, 1998, vol. 78, pp. 216-222).
Sarma et al (Journal of Experimental Medicine, 1999, vol. 189, pp. 811-820).
Paul, Fundamental Immunology, (text), 1993.
Apostolopoulos et al (Nature Medicine, 1998, vol. 4, pp. 315-320).
Jager et al (PNAS, 2000, vol. 97, pp. 12198-12203).
Semino et al (Journal of Biological Regulators and Homeostatic Agents, 1993, vol. 7, pp. 99-105.
Ohlen et al (Journal of Immunology, 2001, vol. 166, pp. 2863-2870).
Antoinia et al (International Immunology, 1995, vol. 7, pp. 715-725).
Yu and Restifo (Journal of Clinical Investigation, 2002, vol. 110, pp. 289-294.
Lee et al (Journal of Immunology, 1999, vol. 163, pp. 6292-6300).
Abstract of Wheeler (Salud p'ublica de M'exico, (Jul.-Aug. 1997) 39 (4) 283-7).
Efferson et al (Anticancer Research, 2005, vol. 25, pp. 715-724).
Bachman et al (Journal of Immunology, 2005, vol. 175, pp. 4677-4685).
Ghose et al (Human Gene Therapy, 2000, vol. 11, pp. 1289-1301).
Schultze et al (Trends in Immunology, 2004, vol. 25, pp. 659-664).
Le Fur et al (PNAS, 1997, vol. 94, pp. 7561-7565).
Finke et al, Immunology Today, 1999, vol. 20, pp. 158-160.
Donnelly et al (Journal of Immunology, Jul. 15, 2005, 175(2):633-639.
Vanniasinkam et al (Journal of Clinical Virology, Aug. 2006, 36(4):292-297).
Young et al (Journal of Pathology, 2006, vol. 208, pp. 299-318).
NCI GenBank database Accession No. AF183810, “Homo sapienszinc finger transcription factor TRPS1 mRNA, complete cds.”
NCI GenBank database Accession No. AAF23614, “zinc finger transcription factor TRPS1 [Homo sapiens]”.
Momeni, P. et al. Mutations in a new gene, encoding a zinc-finger protein, cause tricho-rhino-phalangeal syndrome type I. Nat Genet 24, 71-4 (2000).
Malik, et al. Deletion of the GATA domain of TRPS1 . . . Mol. Cell. Biol. 22, 8592-600 (2002).
Ludecke, H.J. et al. Genotypic and phenotypic spectrum in tricho-rhino-phalangeal syndrome types I and III. Am J Hum Genet 68, 81-91 (2001).
Kaiser, F.J. et al. Novel missense mutations in the TRPS1 transcription factor define the nuclear localization signal. Eur J Hum Genet 12, 121-6 (2004).
Ginestier, C. et al. Distinct and complementary information . . . Am J Pathol 161, 1223-33 (2002).
Kobayashi, H. et al. Missense mutation of TRPS1 in a family of tricho-rhino-phalangeal syndrome type III. Am J Med Genet 107, 26-9 (2002).
Gentile, et al. A novel mutation in exon 7 in a family with mild tricho-rhino-phalangeal syndrome type I. Clin Genet 63, 166-7 (2003).
Hatamura, I. et al. A nonsense mutation in TRPS1 in a Japanese family with tricho-rhino-phalangeal syndrome type I. Clin Genet 59, 366-7 (2001).
Chang, G.T. et al. Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res 57, 4075-81 (1997).
Kunath, M., Ludecke, H.J. & Vortkamp, A. Expression of Trps1 during mouse embryonic development. Mech Dev 119 Suppl 1, S117-20 (2002).
Malik, T.H. et al. Transcriptional repression and developmental functions of the atypical vertebrate GATA protein TRPS1. Embo J 20, 1715-25 (2001).
Chang, G.T. et al. Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. J Natl Cancer Inst 92, 1414-21 (2000).
Kaiser, et al. The RING finger protein RNF4, a co-regulator of transcription, interacts with the TRPS1 transcription factor. J Biol Chem 278, 38780-5 (2003).
Tremblay, J.J. & Viger, R.S. Novel roles for GATA transcription factors in the regulation of steroidogenesis. J Steroid Biochem Mol Biol 85, 291-8 (2003).
Savinainen, et al. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. Br. J. Cancer 90, 1041-1046 (2004).
Williams, et al. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis, 19: 333-343 (1998).
DeRisi, et al. Use of a cDNA microarray to gene expression patterns in human cancer. Nature Genetics 14: 457-460 (1996).
Welford, et al. Detection of differentially expressed genes in primary tumor tissues . . . Nucleic Acids Research 26(12): 3059-3065 (1998).
Khan, et al. Expression profiling in cancer using cDNA microarrays. Electrophoresis 20: 223-229 (1999).
Radvanyi, et al. The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. PNAS 102(31): 11005-11010 (2005).
Berinstein Neil
Cao Shi-Xian
Gallichan Scott
Lovitt Corey
Oomen Raymond P.
Canella Karen A
Halloran Patrick J.
Sanofi Pasteur Limited
LandOfFree
Tumor antigens BFA4 and BCY1 for prevention and / or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor antigens BFA4 and BCY1 for prevention and / or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor antigens BFA4 and BCY1 for prevention and / or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4193687